![](https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/22220127/LGND-insidermonkey-1698026485489.jpg)
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2024 Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2024 Earnings Call Transcript August 6, 2024 Ligand Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $-2.87947 EPS, expectations were $1.1. Operator: Thank you for standing …